AlzInsights AI Collective

Building Shared Tools to Accelerate Discovery

AI tools for Alzheimer's Disease will get built better and faster when developers and experts build them together.  Backed by ~$15 million, the AlzInsights AI Collective brings AI developers and researchers studying Alzheimer's and related dementias together in thematic working groups to create new and powerful tools that can accelerate discovery.

Powered by the AD Data Initiative

About the Collective

AlzInsights AI Collective: Building Shared Tools to Accelerate Discovery
~$15M
AI Collective Catalyst
5
Thematic Working Groups

Connecting developers, researchers, and resources to build AI tools for Alzheimer's disease research faster.

Building effective and responsible AI tools for Alzheimer's disease research takes two kinds of expertise: developers bring the technical skill, and Alzheimer’s experts bring knowledge of the disease, the data, and what will hold up in practice.

The AlzInsights AI Collective is designed to put the people building AI tools in direct contact with the scientists who will use them. Each working group is anchored around a core theme and led by AI innovators. Groups meet on an ongoing basis, bringing together researchers, data scientists and developers to solve a shared problem, exchange data and methods, and test hypotheses.

New tools in each group are designed with responsible safeguards in place and tested against independent data to accelerate science and help new discoveries reach people living with Alzheimer's and their families faster.

Data Harmonization Icon

Data Harmonization and Knowledge Integration

Making disparate Alzheimer's datasets interoperable through harmonization, multimodal integration, knowledge graphs and ontologies.

Lead Advisor:
Courosh Mehanian, University of Oregon, Knight Campus for Accelerating Scientific Impact

AI Co-Scientists and Research Agents

Agentic systems that help formulate hypotheses, interrogate literature and data, and design analyses.

Lead Advisor:

Ayush Noori, University of Oxford

Target Discovery, Drug Repurposing, and Therapeutic Design

Causal biology, target prioritization, repurposing and therapeutic development.

Lead Advisor:

Greg Moore, Senior Advisor, AD Data Initiative & GRIP TAG member

Digital Twins Icon

Digital twins and virtual biology

In silico models of cells, pathways, patients and disease trajectories that support simulation and testing.

Lead Advisor:

TBA

Clinical Translation Icon

Clinical Translation, Biomarkers, and Trial Enablement

Patient stratification, biomarkers, progression prediction, and trial matching.

Lead Advisor:
  
Tom Stocky, Senior Advisor, Gates Ventures & GRIP TAG member

The tools developed in these working groups will be made available to the broader Alzheimer’s research community through AD Workbench.

The AI Collective Catalyst

Housed by the AD Data Initiative and supported by Gates Ventures, West Health, and additional funding partners, the AI Collective Catalyst plans to deploy ~$15M towards 15-20 promising AI opportunities via a grant mechanism. 

The Catalyst also connects donors interested in AI tools for Alzheimer's, so teams don't need to approach each one individually.

Applications for Catalyst support will open in early 2027.

Who should join?

We are looking for people across the research continuum who are passionate about creating tools that will unlock new discoveries in Alzheimer's research.

Developers & Data Scientists

Brainstorm and collaborate with peers working on the same problem. Find researchers to test and improve your tool and become eligible to apply to the Catalyst to speed up development. Launch your tool on AD Workbench.

Researchers

Shape the development of new AI tools from the start and find collaborators to test new research methods. Get early access to tools that can speed up your work or open new avenues of discovery.

Donors

Broaden your impact by funding the AI for Alzheimer’s ecosystem, rather than one tool at a time. The Collective connects innovators already building solutions with researchers who know how to apply them.

Building on the momentum of the Alzheimer’s Insights AI Prize

In 2025, inspired by a Nature Medicine commentary outlining four areas where AI could accelerate Alzheimer's research, the AD Data Initiative launched the Alzheimer's Insights AI Prize. The prize drew more than 180 submissions from teams in over 18 countries. Judges named two winners, doubled the prize investment to $2M, and the AD Data Initiative has continued working with all 10 semifinalists. The AlzInsights AI Collective is the next phase of that work.

180+
Submissions
18+
Countries
2
Winners
10
Semifinalists Carried Forward

The AlzInsights AI Collective and AI Collective Catalyst are made possible by:

AD Data Initiative Logo
Gates Ventures logo
West Health Logo